Treatment of Refractory, Chronic Low Back Pain with Botulinum Neurotoxin A: An Open-Label, Pilot Study

10.1001/archfami.1994.01850170065021

Anderson G . The epidemiology of spinal disorders. In: Frymoyer JW , ed. The Adult Spine: Principles and Practice. New York: Raven Press; 1991:107–46.

10.1097/01.BRS.0000083365.41261.CF

10.1212/WNL.56.10.1290

Lang, 2000, A pilot study of botulinum toxin type A (botox), administered using a novel injection technique, for the treatment of myofascial pain, Am J Pain Manag, 10, 105

Edwards, 2004, Botulinum type A for failed back syndrome, J Pain, 5, 817

10.1016/S0140-6736(01)18475-8

10.1212/WNL.40.2.277

10.1016/j.pain.2003.10.008

10.3109/00016489309135834

10.1038/206588a0

10.1016/S0021-5155(99)00197-5

10.1016/S0041-0101(99)00153-1

10.1007/BF00498587

10.1097/00007632-200004150-00006

10.1038/363543a0

Peng, 2005, The pathogenesis of discogenic low back pain, J Bone Joint Surg Br, 87, 62, 10.1302/0301-620X.87B1.15708

10.1016/0304-3959(94)90048-5

10.1097/00002508-200211001-00010

10.1002/1531-8249(200007)48:1<7::AID-ANA2>3.0.CO;2-O